Clorox Reports Mixed Q4 Results Amid GOJO Integration Challenges — The Clorox Company

Event summary

Clorox reported Q4 net sales of $1.95 billion, down 2% YoY, with the GOJO acquisition adding about 10 points.
Gross margin decreased by 520 basis points to 41.3%, impacted by lower volume and higher costs.
Diluted EPS fell 50% to $1.34 due to integration costs and inventory step-up from the GOJO acquisition.
Full-year net sales declined 5% to $6.72 billion, with organic sales down 8%.
Clorox expects FY2027 net sales growth of 13-14%, driven by lapping ERP-related inventory drawdown.

The big picture

Clorox's mixed Q4 results reflect the challenges of integrating GOJO Industries amid a tough macroeconomic environment. The acquisition expands Clorox's health and hygiene portfolio, now representing over half of net sales, but integration costs and higher operational expenses are weighing on margins. The company's digital transformation and ERP implementation aim to streamline operations, but execution risks remain as it navigates cost volatility and value-seeking consumers.

What we're watching

Integration Execution: How Clorox will manage the ongoing integration of GOJO, particularly adapting to its B2B operating model and realizing anticipated synergies.
Cost Pressures: Whether Clorox can mitigate higher commodity costs and logistics expenses amid continued inflationary headwinds.
Organic Growth Recovery: The pace at which Clorox can return to organic sales growth, particularly as it laps the ERP-related inventory drawdown in FY2027.